This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20251210880760\/en\/<\/a><\/p>\n Owlet announces the UK and Ireland launch of Owlet360\u2122, a new subscription service designed to give parents a deeper, personalized understanding of their baby\u2019s sleep and daily trends.<\/p>\n<\/div>\n \nBuilt for families using medically-certified Dream Sock\u00ae<\/sup> and Dream Sight\u2122 or Owlet Cam\u00ae<\/sup> 2, Owlet360 leverages Owlet\u2019s unique infant dataset to deliver actionable insights and context, helping parents feel more confident in everyday decisions. The Company emphasizes that live vital monitoring of pulse rate and oxygen level, and real-time notifications through the Owlet Dream App, remain free of charge, consistent with its mission to improve access to at-home infant care.\n<\/p>\n \nNew parenthood is joyful \u2013 and relentlessly demanding. In the UK, sleep deprivation is a near-universal early-parent experience, with surveys showing around 59% of parents<\/a> of babies under one reporting their baby sleeps less than four hours at a stretch, and many worrying their baby \u201cshould\u201d be sleeping longer. Owlet360 aims to be a supportive companion, helping parents see how their baby\u2019s sleep and daily patterns evolve over time and how those trends compare across Owlet\u2019s broad population of babies.\n<\/p>\n \n\u201cOwlet\u2019s insights platform is grounded in one of the world\u2019s largest real-world infant datasets from more than 2.5 million babies monitored,\u201d said Jonathan Harris, Owlet\u2019s President and CEO. \u201cGlobally, Owlet has tracked trillions of heartbeats, and these learnings now power personalized interpretations for our UK and Irish customer base. Owlet360 is the next step in our pediatric care ecosystem, turning trusted vitals and sleep data into personalized insights that help families feel supported day to day.\u201d\n<\/p>\n \nOwlet360 extends the experience parents already know in the Owlet Dream App, providing:\n<\/p>\n \nOwlet360 is already demonstrating meaningful adoption and value for families. Following the U.S. launch earlier this year, the service has grown rapidly to more than 90,000 subscribers, highlighting both its relevance in the parenting journey and the durability of Owlet\u2019s recurring-revenue model.\n<\/p>\n Owlet360<\/a> is available now to Owlet Dream App users across the UK and Ireland, with a seven-day free trial for eligible new and existing customers. The service is currently offered via a monthly or yearly subscription, with additional platform expansions planned in the future. To learn more about Owlet and its product offerings, visit owletbabycare.co.uk<\/a>.\n<\/p>\n About Owlet, Inc.<\/b><\/p>\n Owlet, Inc.<\/a> (NYSE: OWLT), a leading pediatric health platform, is the only company in the world to offer U.S. FDA-cleared and internationally medically-certified wearable pediatric monitors, delivering hospital-grade technology directly in the home. Our award-winning pediatric products and innovative software combine clinically tested monitoring systems, an integrated video platform, and a simple, easy-to-use app, providing parents with real-time health insights to stay informed on their child\u2019s well-being, support restful sleep, and provide peace of mind anywhere. Since 2012, more than 2.5 million parents have trusted Owlet to monitor their children’s well-being and sleep. This adoption has fueled one of the largest collections of pediatric health and sleep data in the world, powering innovations that bridge the critical gap between hospital and home. Owlet is driving a new standard in pediatric wellness by pairing advanced medical technology with consumer-friendly design. Our mission is simple yet ambitious: to give every baby and every family the best possible start in life. Learn more at www.owletcare.com<\/a> and follow us on LinkedIn<\/a> and Instagram<\/a> for company news and updates.\n<\/p>\n Forward-Looking Statements<\/b><\/p>\n \nThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the \u201cReform Act\u201d). All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the Company\u2019s launch of Owlet360 in the U.K. and Ireland and the anticipated impacts thereof; the Company\u2019s expectations regarding product adoption, subscriber engagement, and growth trends relating to Owlet360 and its broader platform; the Company\u2019s ability to expand availability of its products and services in additional markets; and the Company\u2019s ability to enhance its technology, product ecosystem, and service offerings over time. In some cases, you can identify forward-looking statements by terms such as \u201cestimate,\u201d \u201cmay,\u201d \u201cbelieves,\u201d \u201cplans,\u201d \u201cexpects,\u201d \u201canticipates,\u201d \u201cintends,\u201d \u201cgoal,\u201d \u201cpotential,\u201d \u201ccontinues,\u201d the negation thereof, or similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking statements are based on the Company\u2019s expectations at the time such statements are made, speak only as of the dates they are made, and are susceptible to a number of risks, uncertainties, and other factors. For all such forward-looking statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the Reform Act. The Company\u2019s actual results, performance or achievements may differ materially from any future results, performance or achievements expressed or implied by its forward-looking statements. Many important factors could affect the Company\u2019s future results and cause those results to differ materially from those expressed in or implied by the Company\u2019s forward-looking statements. Such factors include, but are not limited to: (i) the commercial success of Owlet\u2019s products, including Owlet360, and the Company\u2019s ability to support, scale and maintain its subscription services; (ii) the regulatory pathway for Owlet\u2019s products, including submissions to, actions taken by and decisions and responses from regulators, such as the FDA and similar regulators outside of the United States, as well as Owlet\u2019s ability to obtain and maintain regulatory approval or certification for its products and comply with ongoing regulatory requirements; (iii) the Company\u2019s and its partners\u2019 obligations relating to data privacy, security and the exchange and use of health information, and risks of cybersecurity incidents or changes in applicable standards or interpretations; (iv) the performance of, and Owlet\u2019s ability to maintain and expand, its relationship with third-party technology, cloud, manufacturing and distribution partners; (v) Owlet\u2019s competition and the Company\u2019s ability to profitably grow and manage growth; (vi) the ability of Owlet to implement strategic initiatives, reduce costs, grow revenues, develop and launch new products, innovate and enhance existing products, meet customer demands and adapt to changes in consumer preferences and retail trends; (vii) Owlet\u2019s ability to acquire, defend and protect its intellectual property and satisfy regulatory requirements concerning privacy and data protection; (viii) Owlet\u2019s ability to maintain relationships with channel partners, customers, manufacturers and suppliers; (ix) impacts from compliance with applicable laws or regulations; (x) the impact of and disruption to Owlet\u2019s business, financial condition, operations, supply chain and logistics due to economic and other conditions beyond the Company\u2019s control; (xi) adverse impacts from other economic, business, regulatory, competitive or other factors, such as changes in discretionary consumer spending and consumer preferences; and (xii) other risks and uncertainties set forth in the Company\u2019s other releases, public statements and filings with the U.S. Securities and Exchange Commission (\u201cSEC\u201d), including those identified in the \u201cRisk Factors\u201d section of the Company\u2019s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and as any such factors may be updated from time to time in the Company\u2019s other filings with the SEC. All such forward-looking statements attributable to the Company or any person acting on the Company\u2019s behalf are expressly qualified in their entirety by the cautionary statements contained or referred to above. Moreover, the Company operates in an evolving environment. New risk factors and uncertainties may emerge from time to time, and factors that the Company currently deems immaterial may become material, and it is impossible for the Company to predict such events or how they may affect Owlet. Except as required by law, the Company assumes no obligation to update any forward-looking statements after the date of this press release, whether because of new information, future events or otherwise, although Owlet may do so from time to time. The Company does not endorse any projections regarding future performance that may be made by third parties.\n<\/p>\n View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20251210880760\/en\/<\/a><\/span><\/p>\n Media Contact:![\"Owlet](\"https:\/\/mms.businesswire.com\/media\/20251210880760\/en\/2666560\/4\/Owlet360.jpg\")
<\/p>\n\n
<\/p>\n
\n<\/b>
pr@owletcare.com
\n<\/a><\/p>\n
![\"Photo\"](\"https:\/\/mms.businesswire.com\/media\/20251210880760\/en\/2666560\/3\/Owlet360.jpg\")
<\/td>\n<\/tr>\n![\"Logo\"](\"https:\/\/mms.businesswire.com\/media\/20251210880760\/en\/2666556\/3\/Owlet_Logo.jpg\"){kind=logo}
<\/td>\n<\/tr>\n